Leading drug makers rang in the new year by once again raising list prices of their drugs—this time on more than 250 of them, according to an analysis reported by Reuters…
The larger price tags applied to a range of medications, from blood thinners to cancer therapies and treatments for respiratory conditions, HIV, arthritis, and multiple sclerosis.
Nearly all of the increases were below 10 percent, according to the 3 Axis analysis. So far, the median price increase is around 5 percent, though additional price increases could still be announced.
Don’t worry. They’re not doing themselves any harm. As of November, the 2019 inflation rate was 2.1 percent.